{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:03:43Z","timestamp":1767845023816,"version":"3.49.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2023,2,21]]},"DOI":"10.1001\/jama.2022.24906","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:06:48Z","timestamp":1676995608000},"page":"539","source":"Crossref","is-referenced-by-count":7,"title":["Biomarkers and the Risk of Preeclampsia"],"prefix":"10.1001","volume":"329","author":[{"given":"Ukachi N.","family":"Emeruwa","sequence":"first","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Gyamfi-Bannerman","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise C.","family":"Laurent","sequence":"additional","affiliation":[{"name":"Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Diego, La Jolla"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"jed220116r1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population-based study.","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"issue":"23","key":"jed220116r2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1136\/heartjnl-2011-300949","article-title":"Hypertension in pregnancy: the NICE guidelines.","volume":"97","author":"Redman","year":"2011","journal-title":"Heart"},{"issue":"10","key":"jed220116r3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004659.pub3","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications.","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"9575","key":"jed220116r4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"jed220116r5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force.","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"key":"jed220116r6","article-title":"Aspirin discontinuation at 24 to 28 weeks\u2019 gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial.","author":"Mendoza","journal-title":"JAMA"},{"key":"jed220116r7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia.","volume":"75","author":"MacDonald","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"jed220116r8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers.","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"1","key":"jed220116r9","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"jed220116r10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation.","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"jed220116r11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia.","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"Suppl 1","key":"jed220116r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijgo.2019.145.issue-S1","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention.","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"jed220116r13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice.","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"jed220116r14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/uog.2019.53.issue-1","article-title":"ISUOG Practice Guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia.","volume":"53","author":"Sotiriadis","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"jed220116r15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia.","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"jed220116r16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1471-2393-13-110","article-title":"Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.","volume":"13","author":"Villa","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"jed220116r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247782","article-title":"Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: a systematic review and meta-analysis.","volume":"16","author":"Van Doorn","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"jed220116r18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ajog.2018.03.018","article-title":"Optimal aspirin dosing for preeclampsia prevention.","volume":"219","author":"Seidler","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"jed220116r19","doi-asserted-by":"publisher","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease.","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"jed220116r20","doi-asserted-by":"publisher","first-page":"e2142343","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019.","volume":"5","author":"Wheeler","year":"2022","journal-title":"JAMA Netw Open"},{"key":"jed220116r21","author":"American College of Obstetricians and Gynecologists"},{"issue":"10","key":"jed220116r22","doi-asserted-by":"publisher","first-page":"e2130960","DOI":"10.1001\/jamanetworkopen.2021.30960","article-title":"Miscommunication about low-dose aspirin for preeclampsia prevention: further support for universal prophylaxis.","volume":"4","author":"Lewkowitz","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2801702\/jama_emeruwa_2023_ed_220116_1676478963.5787.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T16:06:50Z","timestamp":1676995610000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2801702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,2,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.24906","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}